<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01943032</url>
  </required_header>
  <id_info>
    <org_study_id>EC 196/2010</org_study_id>
    <nct_id>NCT01943032</nct_id>
  </id_info>
  <brief_title>Discordant Hormonal Status of Breast Cancer.</brief_title>
  <official_title>Discordant Hormonal Status Between Primary Tumor and Axillary Lymph Node in Breast Cancer Patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cancer Institute, Thailand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cancer Institute, Thailand</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine discordant hormonal status of primary breast tumor
      and metastatic breast cancer cells at regional lymph nodes in node positive breast cancer
      patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hormonal status between primary breast tumor and axillary lymph node were analyzed.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2011</start_date>
  <completion_date type="Actual">April 2012</completion_date>
  <primary_completion_date type="Actual">April 2011</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Association of hormonal status between primary breast tumor and axillary lymph nodes</measure>
    <time_frame>Up to 1 year</time_frame>
    <description>Association of estrogen and progesterone status between primary breast tumor and axillary lymph nodes was analyzed by using the Ï‡2 test</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">105</enrollment>
  <condition>Malignant Neoplasm of Breast.</condition>
  <arm_group>
    <arm_group_label>Primary Breast Tumor</arm_group_label>
    <description>Immunohistochemical staining of paraffin embedded tissue blocks of primary breast tumor for estrogen and progesterone receptors was performed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Axillary Lymph Nodes.</arm_group_label>
    <description>Immunohistochemical staining of paraffin embedded tissue blocks of axillary lymph nodes for estrogen and progesterone receptors was performed.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Paraffin embedded tissue blocks of primary breast tumor and axillary lymph nodes.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Breast Cancer Patients Stage I,II and III.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Breast cancer patients stage I,II and III with axillary lymph nodes metastasis.

        Exclusion Criteria:

          -  Breast cancer patients stage I,II and III without axillary lymph nodes metastasis.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>AKANIST PIYAPANT, MD.,FRCST.</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Cancer Institute, Thailand</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Cancer Institute, Thailand.</name>
      <address>
        <city>Ratchathewi</city>
        <state>Bangkok</state>
        <zip>10400</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <reference>
    <citation>Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW, Hayes DF. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004 Aug 19;351(8):781-91.</citation>
    <PMID>15317891</PMID>
  </reference>
  <reference>
    <citation>Cristofanilli M. The biological information obtainable from circulating tumor cells. Breast. 2009 Oct;18 Suppl 3:S38-40. doi: 10.1016/S0960-9776(09)70270-X.</citation>
    <PMID>19914540</PMID>
  </reference>
  <verification_date>September 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 10, 2013</study_first_submitted>
  <study_first_submitted_qc>September 11, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2013</study_first_posted>
  <last_update_submitted>September 19, 2013</last_update_submitted>
  <last_update_submitted_qc>September 19, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 20, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Cancer Institute, Thailand</investigator_affiliation>
    <investigator_full_name>AKANIST PIYAPANT, MD.,FRCST.</investigator_full_name>
    <investigator_title>MD.,FRCST. Surgical Oncologist.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

